Kensington Investment Counsel, LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kensington Investment Counsel, LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$342,218
-33.5%
58,599
-23.7%
0.27%
-37.9%
Q3 2022$515,000
+60.4%
76,801
+0.6%
0.43%
+58.0%
Q2 2022$321,000
+23.9%
76,354
-0.5%
0.27%
+60.2%
Q1 2022$259,000
-3.7%
76,749
-10.2%
0.17%
+8.9%
Q4 2021$269,000
-24.4%
85,483
+1.3%
0.16%
-35.7%
Q2 2021$356,000
-13.4%
84,368
+2.4%
0.24%
-21.0%
Q1 2021$411,000
-57.0%
82,402
+9.1%
0.31%
-60.8%
Q4 2020$955,00075,5330.79%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,420,349$25,814,8383.96%
Parkman Healthcare Partners LLC 1,203,484$7,028,3471.87%
SPHERA FUNDS MANAGEMENT LTD. 1,002,783$5,856,2531.26%
TANG CAPITAL MANAGEMENT LLC 1,150,000$6,716,0000.98%
BVF INC/IL 3,629,000$21,193,3600.89%
Nantahala Capital Management 1,732,388$10,117,1460.66%
AWM Investment Company, Inc. 666,661$3,893,3000.56%
INGALLS & SNYDER LLC 1,295,833$7,5680.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 200,800$1,172,6720.36%
Kensington Investment Counsel, LLC 58,599$342,2180.27%
View complete list of CONCERT PHARMACEUTICALS INC shareholders